Gradient Investments’s HUMANIGEN, INC. HGEN Stock Holding History

Gradient Investments’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,000	Closed	-$144	–	1911
2023 Q1	$144	Hold	1,000	–	–	﹤0.01%	1416
2022 Q4	$120	Hold	1,000	–	–	﹤0.01%	1424
2022 Q3	$0	Hold	1,000	–	–	﹤0.01%	1597
2022 Q2	$2K	Hold	1,000	–	–	﹤0.01%	1091
2022 Q1	$3K	Hold	1,000	–	–	﹤0.01%	1007
2021 Q4	$4K	Buy	1,000 +300	+43%	+$1.75K	﹤0.01%	996
2021 Q3	$4K	Buy	700 +600	+600%	+$8.43K	﹤0.01%	932
2021 Q2	$2K	Sell	100 -100	-50%	-$1.82K	﹤0.01%	1032
2021 Q1	$4K	Buy	+200	New	+$3.65K	﹤0.01%	933

Other funds holding HGEN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.7B AUM 31.52% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Gradient Investments's HGEN Position: Q2 2023 in Review

Gradient Investments sold out of HUMANIGEN, INC. (HGEN) in Q2 2023, closing a stake of 1,000 shares — an estimated $144 sold.

Gradient Investments first reported a position in HGEN in Q1 2021 and held it in 9 quarters. The position peaked at $4K in Q4 2021. 38 funds tracked by Wall St. Rank hold HGEN as of Q2 2023.

Gradient Investments reported no remaining HUMANIGEN, INC. position as of Q2 2023 after selling out during the quarter.
Gradient Investments sold 1,000 HUMANIGEN, INC. shares in Q2 2023, an estimated $144.
Gradient Investments first reported a position in HUMANIGEN, INC. in Q1 2021 and held it in 9 quarters.
Gradient Investments's HUMANIGEN, INC. position peaked at $4K in Q4 2021.
38 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q2 2023.

Based on Gradient Investments's 13F filing for Q2 2023, filed 11 Jul 2023.